CCLA Investment Management Buys 408,360 Shares of Avantor, Inc. (NYSE:AVTR)

CCLA Investment Management grew its stake in Avantor, Inc. (NYSE:AVTR) by 8.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,128,504 shares of the company’s stock after purchasing an additional 408,360 shares during the quarter. CCLA Investment Management owned approximately 0.76% of Avantor worth $109,624,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of AVTR. Versant Capital Management Inc raised its position in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares during the period. Blue Trust Inc. raised its position in shares of Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares during the period. TFO Wealth Partners LLC raised its position in shares of Avantor by 203,100.0% in the fourth quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after purchasing an additional 2,031 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH bought a new position in shares of Avantor in the first quarter valued at about $93,000. Finally, ORG Partners LLC raised its position in shares of Avantor by 5,773.0% in the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after purchasing an additional 5,773 shares during the period. 95.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on AVTR. Stifel Nicolaus upped their price target on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Citigroup downgraded shares of Avantor from a “buy” rating to a “neutral” rating and decreased their price target for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Morgan Stanley upped their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Wells Fargo & Company began coverage on shares of Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price target on the stock. Finally, Barclays upped their price target on shares of Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $27.40.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Avantor Trading Down 1.2 %

Shares of Avantor stock opened at $26.87 on Wednesday. The firm’s 50-day moving average price is $24.67 and its two-hundred day moving average price is $24.30. Avantor, Inc. has a 12-month low of $16.63 and a 12-month high of $28.00. The company has a quick ratio of 1.05, a current ratio of 1.59 and a debt-to-equity ratio of 0.89. The company has a market capitalization of $18.25 billion, a price-to-earnings ratio of 68.90, a PEG ratio of 2.75 and a beta of 1.32.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. On average, analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.